Kontigo Care AB
STO:KONT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (16.2), the stock would be worth kr-1.49 (186% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -18.8 | kr1.73 |
0%
|
| Industry Average | 16.2 | kr-1.49 |
-186%
|
| Country Average | 21.3 | kr-1.96 |
-214%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
K
|
Kontigo Care AB
STO:KONT
|
60.8m SEK | -18.8 | -29.3 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 88.6 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 36.2 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
28.1B USD | 20.3 | 30.9 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.2B AUD | 119.4 | 60.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 23.5 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.2B SEK | 79.2 | 91.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 15.1 | 19.3 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4B USD | 8.6 | 35 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
283.9B INR | -201.6 | 42.8 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY | 80 | -62.1 |
Market Distribution
| Min | 0.6 |
| 30th Percentile | 12.2 |
| Median | 21.3 |
| 70th Percentile | 31.9 |
| Max | 19 008.8 |
Other Multiples
Kontigo Care AB
Glance View
Kontigo Care AB engages in the development of mobile health solutions for addiction treatment. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2015-06-23. The firm operates as a provider of mobile solutions for the treatment of alcoholism. The firm develops TripleA which is a system of care for the treatment of alcoholism. The system consists of a wireless breathalyzer, an application and a health care portal. The portal creates patient care plan and shares it with health care provider. On the basis of this plan, the patient receives information about scheduled sobriety test. Test results are then sent back to the health care provider who can monitor the patient's sobriety every day. The firm operates domestically on the territory of Sweden.
